应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
XLV 健康照护类股ETF-SPDR
盘前交易 09-21 06:35:41 EDT
168.39
-0.42
-0.25%
盘前
167.67
-0.08
-0.05%
05:43 EDT
最高
169.06
最低
167.78
成交量
1,144万
今开
168.27
昨收
168.81
日振幅
0.76%
总市值
434.81亿
流通市值
434.81亿
总股本
2.58亿
成交额
19.26亿
换手率
4.43%
流通股本
2.58亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
德国央行：由于能源和医疗保健因素，德国通胀将保持高位。
智通财经 · 33分钟前
德国央行：由于能源和医疗保健因素，德国通胀将保持高位。
医疗保健板块动态：市场快讯综述
投资观察 · 16:25
医疗保健板块动态：市场快讯综述
发挥税收激励作用 提升居民健康保障能力
同花顺 · 04:03
发挥税收激励作用 提升居民健康保障能力
美国联邦医疗保险与医疗补助服务中心主任梅赫迈特·奥兹：下周将宣布打击医疗保险欺诈的新举措。
智通财经 · 09-19 21:46
美国联邦医疗保险与医疗补助服务中心主任梅赫迈特·奥兹：下周将宣布打击医疗保险欺诈的新举措。
社保补贴直达个人！按个人缴费25%发放，这类人群抓紧申领
微大庆 · 09-19 14:02
社保补贴直达个人！按个人缴费25%发放，这类人群抓紧申领
美国FDA批准Inluriyo（Imlunestrant）联合Verzenio（Abemaciclib）用于治疗ER阳性、HER2阴性、ESR1突变的晚期或转移性乳腺癌成人患者
美股速递 · 09-19 01:55
美国FDA批准Inluriyo（Imlunestrant）联合Verzenio（Abemaciclib）用于治疗ER阳性、HER2阴性、ESR1突变的晚期或转移性乳腺癌成人患者
默沙东Keytruda联合Padcev获欧盟CHMP积极意见，用于可切除肌层浸润性膀胱癌围手术期治疗
美股速递 · 09-18 18:55
默沙东Keytruda联合Padcev获欧盟CHMP积极意见，用于可切除肌层浸润性膀胱癌围手术期治疗
规范免责条款、明确特药清单，三大类医疗险示范条款酝酿中
市场资讯 · 09-17
规范免责条款、明确特药清单，三大类医疗险示范条款酝酿中
商业医疗险迎来行业首版统一示范条款：终结“各自为政”，消费者保护再加码
第一财经 · 09-17
商业医疗险迎来行业首版统一示范条款：终结“各自为政”，消费者保护再加码
世界数据组织设立医疗健康、航运贸易、能源等分支机构
格隆汇 · 09-17
世界数据组织设立医疗健康、航运贸易、能源等分支机构
世界数据组织设立医疗健康、航运贸易、能源等分支机构
智通财经 · 09-17
世界数据组织设立医疗健康、航运贸易、能源等分支机构
肺癌精准治疗新阶段！强生锐珂捷带来给药最便捷、时间最短一线联合治疗选择
上观新闻 · 09-17
肺癌精准治疗新阶段！强生锐珂捷带来给药最便捷、时间最短一线联合治疗选择
强生：锐珂捷®埃万妥单抗注射液在中国上市
智通财经 · 09-16
强生：锐珂捷®埃万妥单抗注射液在中国上市
Circle Pharma融资新动态：Column Group领投，礼来战略入股
美股速递 · 09-16
Circle Pharma融资新动态：Column Group领投，礼来战略入股
九州通、贝因美成立数智医疗健康科技公司
智通财经 · 09-16
九州通、贝因美成立数智医疗健康科技公司
新加坡医疗服务提供商LYC Healthcare IPO定价4美元/股 筹资规模上调67%至2500万美元
中金财经 · 09-16
新加坡医疗服务提供商LYC Healthcare IPO定价4美元/股 筹资规模上调67%至2500万美元
新加坡医疗服务提供商LYC Healthcare IPO定价4美元/股 筹资规模上调67%至2500万美元
智通财经 · 09-16
新加坡医疗服务提供商LYC Healthcare IPO定价4美元/股 筹资规模上调67%至2500万美元
新加坡医疗服务提供商LYC Healthcare IPO定价4美元/股 筹资规模上调67%至2500万美元
智通财经 · 09-16
新加坡医疗服务提供商LYC Healthcare IPO定价4美元/股 筹资规模上调67%至2500万美元
医疗健康板块市场动态综述
投资观察 · 09-16
医疗健康板块市场动态综述
Contineum 股价下跌 9.9%，原因是其与强生合作研发的抗抑郁药中期临床试验失败。
智通财经 · 09-16
Contineum 股价下跌 9.9%，原因是其与强生合作研发的抗抑郁药中期临床试验失败。
加载更多
公司概况
公司名称：
健康照护类股ETF-SPDR
所属市场：
ARCA
上市日期：
--
主营业务：
本基金追踪标普健康板块指数(S&P Health Care Select Sector index)，并将95%以上的资产投资在该指数包含的成分股，其中包含了医疗保健、生物科技、制药相关的公司。 风险提示：标的成分和权重，有可能随着时间的迁移而发生变化。
发行价格：
--
{"stockData":{"symbol":"XLV","market":"US","secType":"STK","nameCN":"健康照护类股ETF-SPDR","latestPrice":168.39,"timestamp":1789761600000,"preClose":168.81,"halted":0,"volume":11441807,"hourTrading":{"tag":"盘前","latestPrice":167.67,"preClose":167.74777,"latestTime":"05:43 EDT","volume":163,"amount":27395.44586,"timestamp":1789983817567,"change":-0.07777,"changeRate":-0.000464,"amplitude":0.007862},"delay":0,"changeRate":-0.002488004265150263,"floatShares":258215324,"shares":258215324,"eps":-14.217021,"marketStatus":"盘前交易","change":-0.42,"latestTime":"09-21 06:35:41 EDT","open":168.27,"high":169.06,"low":167.78,"amount":1925594217.92413,"amplitude":0.007582,"askPrice":168.29,"askSize":700,"bidPrice":167.6,"bidSize":14,"shortable":3,"etf":1,"ttmEps":-14.217021,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1789997400000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":167.74777,"sharesOutstanding":267365324,"nav":168.473549,"aum":42685355407.13,"dividendRate":0.014521,"bidAskSpread":0.000098,"preHourTrading":{"tag":"盘前","latestPrice":167.67,"preClose":167.74777,"latestTime":"05:43 EDT","volume":163,"amount":27395.44586,"timestamp":1789983817567,"change":-0.07777,"changeRate":-0.000464,"amplitude":0.007862},"postHourTrading":{"tag":"盘后","latestPrice":168.5,"preClose":168.39,"latestTime":"19:59 EDT","volume":306142,"amount":51526275.0014,"timestamp":1789775967967,"change":0.11,"changeRate":0.000653,"amplitude":0.005642},"volumeRatio":1.5740305235288274,"optionData":{"bulkOrders":[{"symbol":"XLV","call":false,"expireDate":1863493200000,"strike":"90.0","timestamp":1789746807822,"price":0.7,"volume":15000,"amount":1050000,"type":"+"},{"symbol":"XLV","call":false,"expireDate":1863493200000,"strike":"135.0","timestamp":1789746807822,"price":4.15,"volume":10000,"amount":4150000,"type":"-"}]},"impliedVol":0.2274,"impliedVolPercentile":0.876},"requestUrl":"/m/hq/s/XLV","defaultTab":"news","newsList":[{"id":"2669715298","title":"德国央行：由于能源和医疗保健因素，德国通胀将保持高位。","url":"https://stock-news.laohu8.com/highlight/detail?id=2669715298","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669715298?lang=zh_cn&edition=full","pubTime":"2026-09-21 18:03","pubTimestamp":1789985000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LABU","BK4550","BK4588","BK4585","FLGR","CGVV","XLV","NOBL","XBI","BK4581","FGM","VHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196076014","title":"医疗保健板块动态：市场快讯综述","url":"https://stock-news.laohu8.com/highlight/detail?id=1196076014","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1196076014?lang=zh_cn&edition=full","pubTime":"2026-09-21 16:25","pubTimestamp":1789979119,"startTime":"0","endTime":"0","summary":"0444 GMT - 海天国际在首席执行官增持公司股份后，呈现出颇具吸引力的入场点位，花旗分析师Eric Lau在一份报告中指出。该分析师表示，此次增持的时机也印证了公司下半年盈利复苏的预期。花旗预计，这家塑料注塑机制造商的国内销售将推动其下半年业绩，从而抵消海外销售的疲软态势。该投行预计下半年营收与净利润将分别同比增长2.3%和5.0%。花旗维持其买入评级，目标价定为27港元，理由是估值并不高昂。股价目前上涨3.6%，报17.69港元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","XBI","ITM","XLV","BK4581","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669818728","title":"发挥税收激励作用 提升居民健康保障能力","url":"https://stock-news.laohu8.com/highlight/detail?id=2669818728","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669818728?lang=zh_cn&edition=full","pubTime":"2026-09-21 04:03","pubTimestamp":1789934580,"startTime":"0","endTime":"0","summary":"□ 张旋健全多层次医疗保障体系，是增进民生福祉、提高人民生活品质的重要内容。随着居民收入水平持续提高和人口结构变化，群众的健康保障需求日益多样化，仅靠基本医疗保险难以完全覆盖不 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20260921/c680099086.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20260921/c680099086.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["BK4585","BK4588","BK4581","XLV","XBI","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668905879","title":"美国联邦医疗保险与医疗补助服务中心主任梅赫迈特·奥兹：下周将宣布打击医疗保险欺诈的新举措。","url":"https://stock-news.laohu8.com/highlight/detail?id=2668905879","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668905879?lang=zh_cn&edition=full","pubTime":"2026-09-19 21:46","pubTimestamp":1789825602,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0238689110.USD","LU1093756325.SGD","SG9999014005.SGD","BK4566","BK4581","XLV","BK4154","LU0390134368.USD","RSPH","LU0266013472.USD","LU0320765489.SGD","LU0208291251.USD","LU0256863811.USD","HUM","SG9999014013.SGD","BK4585","LU0170899867.USD","BK4533","LABU","IHF","LU0417517546.SGD","XHS","LU0348723411.USD","LU1983260115.SGD","SG9999014021.USD","LU0211331839.USD","XBI","FXH","LU1093756168.USD","BK4588","LU0070302665.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668977547","title":"社保补贴直达个人！按个人缴费25%发放，这类人群抓紧申领","url":"https://stock-news.laohu8.com/highlight/detail?id=2668977547","media":"微大庆","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668977547?lang=zh_cn&edition=full","pubTime":"2026-09-19 14:02","pubTimestamp":1789797720,"startTime":"0","endTime":"0","summary":"延续实施扩大社会保险补贴范围政策至2026年底，直接补给个人，最长可领12个月！按照基本养老保险费、基本医疗保险费、失业保险费个人实际缴纳额的25%给予补贴。补贴通过“先缴后补”的方式按月发放，申领期限截至2026年底，每人累计享受补贴期限不超过12个月。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-09-19/doc-inisiwwa9842638.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["XBI","XLV","BK4585","BK4588","BK4581","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164434045","title":"美国FDA批准Inluriyo（Imlunestrant）联合Verzenio（Abemaciclib）用于治疗ER阳性、HER2阴性、ESR1突变的晚期或转移性乳腺癌成人患者","url":"https://stock-news.laohu8.com/highlight/detail?id=1164434045","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1164434045?lang=zh_cn&edition=full","pubTime":"2026-09-19 01:55","pubTimestamp":1789754137,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局（FDA）已正式批准礼来公司（Eli Lilly）的Inluriyo（Imlunestrant）与Verzenio（Abemaciclib）联合用药方案，该方案适用于患有雌激素受体阳性（ER+）、人表皮生长因子受体2阴性（HER2-）且携带ESR1突变的晚期或转移性乳腺癌成人患者。这一批准标志着针对这一特定患者群体治疗选择的重要进展。值得注意的是，ESR1突变通常与内分泌治疗耐药相关，而此次获批的联合疗法或将为这类难治性患者提供新的治疗路径。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MHIP","LU2461242641.AUD","BK4533","BK4585","IE0001KFT4U8.USD","IE00BN29S564.USD","LU0198837287.USD","IE00BJJMRZ35.SGD","LU0708995401.HKD","LU1061106388.HKD","LU1868836757.USD","LU2112291526.USD","LU2237438978.USD","LU1551013342.USD","LU0006306889.USD","LU0079474960.USD","LU2023251221.USD","LU0385154629.USD","IE0004445015.USD","LU2324357040.USD","LU2750360641.GBP","BK4599","LU0943347566.SGD","LU0823416689.USD","LU2264538146.SGD","LU0432979614.USD","IE00B4R5TH58.HKD","MEDI","LLY","LU0882574055.USD","ILDR","IE00BJJMRY28.SGD","LU1629891620.HKD","LU1267930730.SGD","LU1720051017.SGD","LU2023250504.SGD","LU0109394709.USD","LU2237443549.SGD","LU0109391861.USD","LU1868837136.USD","PPH","LU0640476718.USD","LU1989771016.USD","LU2028103732.USD","LU0106261372.USD","LU0210536198.USD","LLII","LU1323610961.USD","LU2552382215.SGD","HRTS","IE00BKPKM429.USD","IE00BFSS7M15.SGD","LU1035775433.USD","IE0004445239.USD","LU2357305700.SGD","LU0417517546.SGD","IE00B1BXHZ80.USD","IXJ","BK4534","LU0094547139.USD","LU2237443978.SGD","FTXH","THNR","LU1979441026.SGD","LU2023250330.USD","LLYX","LU1127390331.HKD","SGXZ31699556.SGD","SGXZ99366536.SGD","LU0786609619.USD","LU1023059063.AUD","LU1720051108.HKD","IE00BK4W5L77.USD","LU2746668974.SGD","SG9999013999.USD","LU2552382132.HKD","IE00BWXC8680.SGD","LU0964807845.USD","IE00BJJMRX11.SGD","LU0234572021.USD","LU0320765992.SGD","LU0672654240.SGD","LU2237443465.HKD","LU1232071149.USD","LU2237443382.USD","LU2756315318.SGD","GB00BDT5M118.USD","IE00BK4W5M84.HKD","ELIL","LU0256863811.USD","TMED","LU2456880835.USD","LU1868836914.USD","LU2462157665.USD","LU1064131342.USD","LU2750360997.AUD","SG9999014898.SGD","FHLC","LU0203201768.USD","IE00B7KXQ091.USD","LU0353189763.USD","MEDX","JDOC","LU1814569148.SGD","LU2271345857.HKD","BK4516","LU2211815571.USD","LU2602419157.SGD","LU2361044865.SGD","SGXZ57979304.SGD","LU1057294990.SGD","SG9999014880.SGD","CANC","LU2168564222.USD","LU0823434740.USD","LU0683600562.USD","LU2746668461.USD","LU1623119135.USD","LU0225283273.USD","LU2106854487.HKD","LLYZ","LU0061475181.USD","BK4007","LU0354030438.USD","SG9999015952.SGD","LU0820561909.HKD","LU0456855351.SGD","LU0820561818.USD","IE0005OL40V9.USD","LU0345770993.USD","LU2756315664.SGD","PJP","LU2491049909.HKD","IE00B1XK9C88.USD","SG9999015986.USD","LU2265009873.SGD","IE00BFTCPJ56.SGD","OZEM","LU0114720955.EUR","SG9999018857.SGD","LU0174119429.USD","LU2471134879.HKD","RXL","SG9999018865.SGD","LU2168564065.EUR","LU0256863902.USD","LU2108987350.USD","LU2552382058.USD","LU0316494557.USD","LU2168564149.EUR","IE00B2B36J28.USD","LU2237443622.USD","SG9999014914.USD","LU2111349929.HKD","LU0353189680.USD","LU0889565916.HKD","LU2168563687.JPY","IHE","LU1551013425.SGD","LU2471134952.CNY","LU0882574139.USD","LU1712237335.SGD","LU2089283258.USD","IE00BJLML261.HKD","LU2236285917.USD","CURE","BK4581","LU2360106947.USD","TRUH","LU1093756168.USD","LU2468319806.SGD","LU2168564495.EUR","AGNG","LU0320765059.SGD","IYH","IE00B775H168.HKD","IE00BFSS8Q28.SGD","LU1804176565.USD","LU0289739699.SGD","LU2471134523.USD","SG9999015945.SGD","LU0323591593.USD","SG9999014906.USD","SG9999017495.SGD","LU0466842654.USD","IE00B4JS1V06.HKD","LU1548497426.USD","LU1988902786.USD","LU2361044949.HKD","XLV","LU0823434583.USD","LU2491050071.SGD","LU2462591350.SGD","LU1983299246.USD","SG9999001176.SGD","LU0471298694.HKD","SGXZ81514606.USD","BK4588","ELIS","LU2361045086.USD","IE0002141913.USD","LU2491050154.USD","LU1868837300.USD","LU0266013472.USD","LU2237443895.HKD","LU0158827781.USD","VHT","LU1069344957.HKD","LU0238689110.USD","LU0345770308.USD","LU2063271972.USD","LU2089284900.SGD","WDNA","IE00BKDWB100.SGD","LU0471298777.SGD","IE0009355771.USD","LU2417539215.USD","LU0122379950.USD","LU0097036916.USD","LU1868836591.USD","LU0096364046.USD","LU0058720904.USD","LU0133085943.USD","LU1280957306.USD","LU1917777945.USD","LU2087625088.SGD","LU0203202063.USD","LU0787776722.HKD","LU2471134796.USD","SGXZ51526630.SGD","GDOC","LU2213496289.HKD","IE00BJT1NW94.SGD","LU1093756325.SGD","LU1974910355.USD","SG9999001176.USD","LU0158827948.USD","LU0689472784.USD","LU1145028129.USD","SG9999015978.USD","LU0820562030.AUD","LU2089984988.USD","LU1366192091.USD","LU1691799644.USD","LU2896262040.SGD","LU0354030511.USD","LU1291159041.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133023101","title":"默沙东Keytruda联合Padcev获欧盟CHMP积极意见，用于可切除肌层浸润性膀胱癌围手术期治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=1133023101","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1133023101?lang=zh_cn&edition=full","pubTime":"2026-09-18 18:55","pubTimestamp":1789728953,"startTime":"0","endTime":"0","summary":"默沙东宣布，其明星药物Keytruda与Padcev的联合疗法，已获得欧洲药品管理局人用药品委员会的积极意见。该意见支持将这一组合方案作为可切除肌层浸润性膀胱癌成人患者的围手术期治疗选择。若获批，该联合疗法将成为欧洲首个针对此类癌症的围手术期免疫联合抗体药物偶联物治疗方案。此次CHMP的积极意见，基于一项名为KEYNOTE-868/EV-304的III期临床试验数据。膀胱癌是全球第十大常见癌症，每年新发病例约57万例，其中约四分之一的患者在确诊时已处于肌层浸润阶段。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0868494708.USD","SG9999014559.SGD","LU0823416689.USD","LU1571399168.USD","LU0859254822.USD","LU0057025933.USD","LU1037948541.HKD","LU0965509283.SGD","SG9999001176.USD","LU0432979614.USD","IE00BBT3K403.USD","JDOC","SG9999002224.SGD","LU2433249047.HKD","LU1066051498.USD","LU0266013472.USD","LU0130102774.USD","LU0006306889.USD","BK4588","SG9999015358.SGD","LU0069063385.USD","VHT","FHLC","LU1162221912.USD","LU2491050071.SGD","LU0965509101.SGD","LU2023250504.SGD","IE00BLSP4239.USD","PAWZ","SG9999015341.SGD","IE000M9KFDE8.USD","LU1430594728.SGD","LU0211331839.USD","IE00BN8TJ469.HKD","LU1291159041.SGD","LU1201861249.SGD","IE00BSNM7G36.USD","FTXH","IE00BFTCPJ56.SGD","LU0648001328.SGD","IE00B4R5TH58.HKD","IE00B1BXHZ80.USD","LU1093756168.USD","LU1941712348.USD","LU2106854487.HKD","MRK","SG9999013999.USD","LU1585245621.USD","LU0689626769.HKD","LU2125909593.SGD","LU2357627491.SGD","LU2125154935.USD","LU1066051225.USD","LU0985320562.USD","LU0162691827.USD","IE00BJJMRZ35.SGD","LU0234572021.USD","BK4007","IYH","LU0511384066.AUD","IE00B2B36J28.USD","IHE","LU1923622614.USD","LU0965509010.AUD","LU0868494617.USD","LU0289739343.SGD","LU1032466523.USD","HRTS","LU1066051811.HKD","LU0203347892.USD","LU1069347547.HKD","LU2023250843.SGD","LU1934455194.USD","SG9999014542.SGD","LU2324357040.USD","LU1934455863.HKD","SG9999014575.USD","LU2360032135.SGD","LU2125154778.USD","LU2089984988.USD","LU1989772923.USD","LU0238689110.USD","LU2491050154.USD","LU2361045086.USD","RXL","LU0861579265.USD","LU0980610538.SGD","LU1035773651.USD","LU2468319806.SGD","LU1061106388.HKD","LU1093756325.SGD","LU0477156953.USD","LU1066053197.SGD","LU0265550359.USD","LU2491049909.HKD","LU0320765646.SGD","LU1057294990.SGD","SG9999001440.SGD","GDOC","BK4534","LU1037948897.HKD","LU2125909247.SGD","SG9999001176.SGD","BK4585","LU0106261372.USD","LU1929549753.HKD","SG9999014567.USD","TRUH","PPH","LU1983299246.USD","BK4550","LU1934455277.USD","XLV","LU2112291526.USD","LU0130517989.USD","IXJ","LU0203345920.USD","LU1116320737.USD","BK4559","LU0058720904.USD","LU1989772840.SGD","IE0002141913.USD","LU1023059063.AUD","LU2361044949.HKD","LU0070302665.USD","LU2461242641.AUD","LU0289961442.SGD","LU0124676726.USD","LU0122379950.USD","IE00BLSP4452.SGD","IE00BJT1NW94.SGD","LU1699723380.USD","LU1989771016.USD","LU0072461881.USD","BK4533","LU0289739699.SGD","LU0208291251.USD","LU0320765489.SGD","LU0472753341.HKD","IE0009355771.USD","LU1941712264.USD","SGXZ57979304.SGD","LU0965508806.USD","LU0942090050.USD","LU0098860793.USD","LU1974910355.USD","LU2361044865.SGD","BK4516","LU1917777945.USD","BMED","SG9999002232.USD","LU1116320901.HKD","LU0265550946.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668967812","title":"规范免责条款、明确特药清单，三大类医疗险示范条款酝酿中","url":"https://stock-news.laohu8.com/highlight/detail?id=2668967812","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668967812?lang=zh_cn&edition=full","pubTime":"2026-09-17 20:36","pubTimestamp":1789648560,"startTime":"0","endTime":"0","summary":"消费者在投保过程中容易忽视免责条款进而引发纠纷乃至投诉。此外，在特定药品费用保障方面，示范条款将明确保险公司约定的特定药品清单，需涵盖保险业协会发布的商业健康保险药品保障清单，为药品保障清单落地实施和动态调整预留衔接空间，进一步满足人民群众看病用药需求，促进保险、医疗、医药产业协同，支持生物医药新兴产业高质量发展。而免责条款的制定，则为了规范保险业务活动、维护保险活动当事人合法权益。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-09-17/doc-iniscvfx3662502.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["XLV","BK4588","XBI","LABU","BK4581","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668966061","title":"商业医疗险迎来行业首版统一示范条款：终结“各自为政”，消费者保护再加码","url":"https://stock-news.laohu8.com/highlight/detail?id=2668966061","media":"第一财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668966061?lang=zh_cn&edition=full","pubTime":"2026-09-17 18:39","pubTimestamp":1789641540,"startTime":"0","endTime":"0","summary":"商业医疗险即将迎来行业首版统一示范条款。9月16日，中国保险行业协会发布长期医疗险、短期医疗险及城市定制型商业医疗保险示范条款征求意见稿。这是商业医疗险三大品类首次被纳入统一的合同范本框架。多位业内人士指出，这意味着长期“各自为政”的医疗险条款，终于有了统一的“基准线”。正因如此，消费者保护成为本次征求意见稿的重点规范之一。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2026-09-17/doc-iniscvfv3934997.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-09-17/doc-iniscvfv3934997.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["XBI","XLV","BK4581","LABU","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668696372","title":"世界数据组织设立医疗健康、航运贸易、能源等分支机构","url":"https://stock-news.laohu8.com/highlight/detail?id=2668696372","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668696372?lang=zh_cn&edition=full","pubTime":"2026-09-17 17:49","pubTimestamp":1789638576,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["159945","XBI","BK4588","IXJ","VHT","BK4550","XLV","BDRY","BOAT","LABU","159760","BK4585","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668963286","title":"世界数据组织设立医疗健康、航运贸易、能源等分支机构","url":"https://stock-news.laohu8.com/highlight/detail?id=2668963286","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668963286?lang=zh_cn&edition=full","pubTime":"2026-09-17 17:42","pubTimestamp":1789638159,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4550","IXJ","BK4585","VHT","BOAT","LABU","XBI","BDRY","BK4581","XLV","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668954182","title":"肺癌精准治疗新阶段！强生锐珂捷带来给药最便捷、时间最短一线联合治疗选择","url":"https://stock-news.laohu8.com/highlight/detail?id=2668954182","media":"上观新闻","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668954182?lang=zh_cn&edition=full","pubTime":"2026-09-17 15:06","pubTimestamp":1789628797,"startTime":"0","endTime":"0","summary":"强生公司日前举办锐珂捷——埃万妥单抗注射液（皮下注射）上市新闻发布会。目前，锐珂捷已获批联合利珂（兰泽替尼），用于经检测确认携带表皮生长因子受体（EGFR）突变的晚期非小细胞肺癌（NSCLC）患者的一线治疗。锐珂捷是中国首个且目前唯一获批用于治疗EGFR突变晚期NSCLC患者的皮下注射制剂，联合利珂在一线联合治疗中展现出显著的给药便捷性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609173877268321.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609173877268321.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU2602419157.SGD","MEDX","LU0640476718.USD","IE00B1BXHZ80.USD","LU0210528500.USD","PJP","LU2896262040.SGD","LU1280957306.USD","LU2129689514.USD","BMED","LU0345770308.USD","LU1551013425.SGD","JNJ","IHE","LU1023059063.AUD","LU0122379950.USD","LU1629891620.HKD","BK4533","LU2417539215.USD","IE00BVYPNW00.USD","RXL","LU0795875086.SGD","LU1244550221.USD","IYH","LU1043141396.HKD","LU0545039389.USD","LU0289739343.SGD","IE000BZT7R73.USD","JDOC","LU0661504455.SGD","LU1244550494.USD","LU2430703095.HKD","LU0114720955.EUR","XLV","LU1244550577.SGD","IXJ","LU0912757837.SGD","LU0124676726.USD","GDOC","LU1196500208.SGD","LU1929549753.HKD","LU2430703178.SGD","LU0345770993.USD","LU2756315664.SGD","SG9999013999.USD","FHLC","VHT","TRUH","FTXH","LU1267930813.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667885079","title":"强生：锐珂捷®埃万妥单抗注射液在中国上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2667885079","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667885079?lang=zh_cn&edition=full","pubTime":"2026-09-16 19:49","pubTimestamp":1789559357,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["PJP","LU1718418525.SGD","LU1074936037.SGD","LU0943347566.SGD","FTXH","LU1043141123.HKD","LU0795875086.SGD","LU1196500208.SGD","JNJ","IHE","FHLC","LU2403377893.USD","IXJ","LU2417539215.USD","XLV","LU2756315318.SGD","LU0345769128.USD","LU0162691827.USD","BK4581","BMED","LU0122379950.USD","LU0426412945.USD","LU1061106388.HKD","LU0203345920.USD","MEDX","SG9999001440.SGD","BK4585","SGXZ57979304.SGD","LU0098860793.USD","LU0689472784.USD","IPOS","LU0738911758.USD","JDOC","LU1894683348.USD","RXL","TRUH","LU0345770308.USD","IE00BFTCPJ56.SGD","LU1280957306.USD","IE00B1BXHZ80.USD","IE000SO60NU8.SGD","BK4532","IE0034235303.USD","IYH","IE00B2B36J28.USD","LU0426417589.USD","LU1162221912.USD","VHT","IE00B4R5TH58.HKD","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149338058","title":"Circle Pharma融资新动态：Column Group领投，礼来战略入股","url":"https://stock-news.laohu8.com/highlight/detail?id=1149338058","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1149338058?lang=zh_cn&edition=full","pubTime":"2026-09-16 19:06","pubTimestamp":1789556772,"startTime":"0","endTime":"0","summary":"Circle Pharma近日宣布完成新一轮融资。此轮融资由Column Group领投，Nextech Invest与Ra Capital Management共同参与。值得注意的是，礼来公司也以战略投资者的身份加入其中。多方资本汇聚，既体现了投资界对Circle Pharma前景的认可，也凸显了制药巨头礼来在创新疗法领域的布局意图。从投资方结构来看，既有深耕生物医药的专业风投，也有全球领先的药企巨头，这种组合往往意味着更深层的战略协同可能性。Circle Pharma的研发管线或将成为这些资本力量交汇的焦点所在。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BK4W5L77.USD","LU0158827781.USD","AGNG","IE00BN29S564.USD","RXL","LU0210536198.USD","LU0943347566.SGD","LU1093756325.SGD","LU0114720955.EUR","LU2461242641.AUD","LU2471134523.USD","LU0385154629.USD","LU1868837300.USD","SG9999014906.USD","LU0471298777.SGD","LU2108987350.USD","IYH","LU2324357040.USD","LU2089984988.USD","LU0466842654.USD","LU0456855351.SGD","ILDR","LU0683600562.USD","LU2417539215.USD","LU2456880835.USD","SGXZ57979304.SGD","LU0417517546.SGD","LU0238689110.USD","BK4588","LU0109391861.USD","LU0889565916.HKD","SG9999017495.SGD","XLV","LU1623119135.USD","LU2111349929.HKD","SG9999013999.USD","LU1712237335.SGD","LU2746668461.USD","SG9999015986.USD","LU1988902786.USD","IE00B775H168.HKD","IE00B1BXHZ80.USD","LU1868837136.USD","BK4581","LU0882574139.USD","LU0708995401.HKD","LU2236285917.USD","LU2552382132.HKD","LU2237443382.USD","SG9999001176.SGD","LU2089283258.USD","LU2237443465.HKD","LU0174119429.USD","LU0109394709.USD","LU1280957306.USD","LU2357305700.SGD","SGXZ31699556.SGD","PJP","LU2237443895.HKD","OZEM","TRUH","LU0640476718.USD","LU0471298694.HKD","LU0122379950.USD","ELIL","LU2106854487.HKD","LU0006306889.USD","LU2602419157.SGD","LU0964807845.USD","LU0133085943.USD","SG9999014898.SGD","IE00BJJMRY28.SGD","GB00BDT5M118.USD","LU1366192091.USD","IE0009355771.USD","WDNA","IE00B7KXQ091.USD","LU1232071149.USD","IE00BWXC8680.SGD","LU0689472784.USD","SG9999018865.SGD","LU2063271972.USD","LLY","LU2213496289.HKD","HRTS","LU0823416689.USD","LU1804176565.USD","LU0094547139.USD","LU0061475181.USD","LU0320765059.SGD","LU2552382058.USD","MHIP","LU1868836591.USD","LU0823434583.USD","LU0672654240.SGD","LU1868836914.USD","LU0787776722.HKD","LU2468319806.SGD","LU0882574055.USD","LU1127390331.HKD","LU2491050154.USD","IE00BKDWB100.SGD","SG9999015945.SGD","BK4585","IE0002141913.USD","LU1720051017.SGD","LU0823434740.USD","LU0820561909.HKD","LU1023059063.AUD","LU1691799644.USD","LU0106261372.USD","BK4599","LU2264538146.SGD","LU0820561818.USD","SG9999014880.SGD","LU1551013342.USD","LU0323591593.USD","LU1061106388.HKD","LU2087625088.SGD","IE0005OL40V9.USD","IE00BFTCPJ56.SGD","LU0820562030.AUD","LU2089284900.SGD","LU2211815571.USD","IE00B4R5TH58.HKD","LU1069344957.HKD","LU2750360641.GBP","PPH","IE00BJJMRZ35.SGD","LU1291159041.SGD","LU2023250330.USD","LU2552382215.SGD","BK4534","LU0097036916.USD","SG9999018857.SGD","IE00BJJMRX11.SGD","LU0353189680.USD","LU0256863811.USD","LU1814569148.SGD","LU1629891620.HKD","ELIS","LU0316494557.USD","LU2462591350.SGD","LU2491049909.HKD","SG9999015978.USD","IE0004445239.USD","IE00B4JS1V06.HKD","LU0203201768.USD","LU2360106947.USD","LU2237443622.USD","LLYZ","LU0256863902.USD","LU1035775433.USD","IE00BKPKM429.USD","LU2168563687.JPY","VHT","CURE","LU2756315664.SGD","LU1868836757.USD","LU2361044949.HKD","LU2756315318.SGD","LU2168564495.EUR","LU1145028129.USD","BK4533","LU2023250504.SGD","LU1551013425.SGD","LU2361045086.USD","LU2491050071.SGD","SG9999014914.USD","LU0354030511.USD","LU2462157665.USD","IE00BFSS8Q28.SGD","LU0353189763.USD","LU2168564222.USD","LU2361044865.SGD","MEDI","IE00BJLML261.HKD","LU2471134796.USD","SG9999015952.SGD","LU2265009873.SGD","LU1093756168.USD","LU1989771016.USD","LU2028103732.USD","IE00BFSS7M15.SGD","LU0079474960.USD","LU2023251221.USD","LU0432979614.USD","LU2750360997.AUD","LU2168564149.EUR","LU2896262040.SGD","SG9999001176.USD","SGXZ81514606.USD","LU0786609619.USD","LU0158827948.USD","LU2271345857.HKD","JDOC","LU0234572021.USD","LU2112291526.USD","LU1720051108.HKD","THNR","TMED","IE0001KFT4U8.USD","FHLC","LU1323610961.USD","CANC","LLYX","IXJ","LU1064131342.USD","LU0345770308.USD","LU0225283273.USD","SGXZ51526630.SGD","BK4516","LU1057294990.SGD","LU2237438978.USD","LU2237443549.SGD","LU1548497426.USD","LU2471134952.CNY","LU0320765992.SGD","LU0203202063.USD","SGXZ99366536.SGD","LU1974910355.USD","LLII","FTXH","LU0345770993.USD","LU2237443978.SGD","LU1267930730.SGD","MEDX","LU2746668974.SGD","LU0266013472.USD","LU2471134879.HKD","LU0058720904.USD","IE00B2B36J28.USD","GDOC","LU0289739699.SGD","IE0004445015.USD","IE00BJT1NW94.SGD","LU0354030438.USD","BK4007","LU1917777945.USD","IE00B1XK9C88.USD","LU0198837287.USD","LU0096364046.USD","LU2168564065.EUR","IHE","LU1979441026.SGD","IE00BK4W5M84.HKD","LU1983299246.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667603419","title":"九州通、贝因美成立数智医疗健康科技公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2667603419","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667603419?lang=zh_cn&edition=full","pubTime":"2026-09-16 15:34","pubTimestamp":1789544041,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4585","BK4550","VHT","XLV","LABU","BK4588","IXJ","BK4581","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667158608","title":"新加坡医疗服务提供商LYC Healthcare IPO定价4美元/股 筹资规模上调67%至2500万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2667158608","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667158608?lang=zh_cn&edition=full","pubTime":"2026-09-16 14:57","pubTimestamp":1789541822,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，在新加坡运营医疗诊所和骨科手术中心的LYC Healthcare于周二提高了即将进行的首次公开募股的拟议发行规模。该公司目前计划发行630万股股票，拟议发行价为每股4美元，以筹集2500万美元。此前，公司已提交文件，计划发行300万股，发行价区间为每股4至6美元。按照调整后的发行规模，LYC Healthcare预计募资金额将较此前预期高出67%，对应市值将达到1.37亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260916/32371585.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK4581","STmain","UDN","LABU","XLV","IPOS","UUP","MEDX","BK4588","BK4585","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667670478","title":"新加坡医疗服务提供商LYC Healthcare IPO定价4美元/股 筹资规模上调67%至2500万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2667670478","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667670478?lang=zh_cn&edition=full","pubTime":"2026-09-16 14:28","pubTimestamp":1789540088,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，在新加坡运营医疗诊所和骨科手术中心的LYC Healthcare于周二提高了即将进行的首次公开募股的拟议发行规模。按照调整后的发行规模，LYC Healthcare预计募资金额将较此前预期高出67%，对应市值将达到1.37亿美元。LYC Healthcare成立于2017年，是一家位于新加坡的多学科专科医疗服务提供商，通过两家运营子公司、5家医疗诊所以及内部先进影像设施，提供一体化的肌肉骨骼医疗服务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1496725.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IPOS","STmain","BK4581","BK4588","LABU","MEDX","XLV","XBI","BK4585","UDN","UUP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667670424","title":"新加坡医疗服务提供商LYC Healthcare IPO定价4美元/股 筹资规模上调67%至2500万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2667670424","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667670424?lang=zh_cn&edition=full","pubTime":"2026-09-16 14:28","pubTimestamp":1789540088,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["XBI","UDN","UUP","LABU","XLV","BK4585","BK4588","IPOS","MEDX","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142651526","title":"医疗健康板块市场动态综述","url":"https://stock-news.laohu8.com/highlight/detail?id=1142651526","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1142651526?lang=zh_cn&edition=full","pubTime":"2026-09-16 04:52","pubTimestamp":1789505567,"startTime":"0","endTime":"0","summary":"医疗健康领域最新市场快讯，涵盖多家药企与医疗器械公司的股价波动与分析师观点。市场表现方面，阿斯利康股价上涨2.25%，报163.78美元。该股目前下跌1.9%，报113.20瑞郎。杰富瑞对Immutep转持看多立场，分析师David Stanton认为这家生物技术公司的主要候选药物有了更清晰的发展路径。Stanton将评级从持有上调至买入，对该澳大利亚公司关于肺癌研究提前终止似乎与临床因素或试验执行无关的更新感到鼓舞。杰富瑞将目标价翻倍至8澳分。该股持平于4.7澳分。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLV","BK4581","BK4585","LABU","XBI","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667296846","title":"Contineum 股价下跌 9.9%，原因是其与强生合作研发的抗抑郁药中期临床试验失败。","url":"https://stock-news.laohu8.com/highlight/detail?id=2667296846","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667296846?lang=zh_cn&edition=full","pubTime":"2026-09-16 01:17","pubTimestamp":1789492646,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00B42XCP33.USD","IBBJ","LU0072461881.USD","LU1929549753.HKD","LU0345769631.USD","IBBQ","IYH","MDTX","JDOC","LU1032955483.USD","IHE","GDOC","LU2403377893.USD","RXL","LU1244550577.SGD","IXJ","LU0820561818.USD","LU2468319806.SGD","IE00BJT1NW94.SGD","LU0124676726.USD","FHLC","LU0889566641.SGD","LU1430594728.SGD","LU0203345920.USD","IE00BFTCPJ56.SGD","LU0432979614.USD","LU0792757196.USD","PSYK","IE000SO60NU8.SGD","BK4568","PJP","JNJ","LU0289739699.SGD","LU0545562505.USD","TRUH","XLV","LU1228905540.USD","LU0689626769.HKD","LU1162221912.USD","LU1629891620.HKD","MEDX","FTXH","IE00BFXG1179.USD","LU1585245621.USD","LU1989771016.USD","LU1674673691.USD","BMED","VHT","IE00B19Z3B42.SGD","LU2417539215.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://us.spdrs.com/etf/health-care-select-sector-spdr-fund-XLV","stockEarnings":[{"period":"1week","weight":0.0183},{"period":"1month","weight":-0.0415},{"period":"3month","weight":0.1271},{"period":"6month","weight":0.1587},{"period":"1year","weight":0.2249},{"period":"ytd","weight":0.0878}],"compareEarnings":[{"period":"1week","weight":-0.0034},{"period":"1month","weight":-0.0096},{"period":"3month","weight":0.02},{"period":"6month","weight":0.1744},{"period":"1year","weight":0.1501},{"period":"ytd","weight":0.117}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"本基金追踪标普健康板块指数(S&P Health Care Select Sector index)，并将95%以上的资产投资在该指数包含的成分股，其中包含了医疗保健、生物科技、制药相关的公司。\n风险提示：标的成分和权重，有可能随着时间的迁移而发生变化。","yearOnYearQuotes":[{"month":1,"riseRate":0.607143,"avgChangeRate":0.009527},{"month":2,"riseRate":0.571429,"avgChangeRate":-0.002019},{"month":3,"riseRate":0.571429,"avgChangeRate":0.0058},{"month":4,"riseRate":0.535714,"avgChangeRate":0.012982},{"month":5,"riseRate":0.678571,"avgChangeRate":0.005168},{"month":6,"riseRate":0.535714,"avgChangeRate":0.004899},{"month":7,"riseRate":0.642857,"avgChangeRate":0.011974},{"month":8,"riseRate":0.571429,"avgChangeRate":0.003309},{"month":9,"riseRate":0.357143,"avgChangeRate":-0.015839},{"month":10,"riseRate":0.592593,"avgChangeRate":0.007405},{"month":11,"riseRate":0.777778,"avgChangeRate":0.02456},{"month":12,"riseRate":0.666667,"avgChangeRate":0.010581}],"exchange":"ARCA","name":"健康照护类股ETF-SPDR","nameEN":"Health Care Select Sector SPDR Fund"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.0","shortVersion":"4.50.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"健康照护类股ETF-SPDR(XLV)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供健康照护类股ETF-SPDR(XLV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"健康照护类股ETF-SPDR,XLV,健康照护类股ETF-SPDR股票,健康照护类股ETF-SPDR股票老虎,健康照护类股ETF-SPDR股票老虎国际,健康照护类股ETF-SPDR行情,健康照护类股ETF-SPDR股票行情,健康照护类股ETF-SPDR股价,健康照护类股ETF-SPDR股市,健康照护类股ETF-SPDR股票价格,健康照护类股ETF-SPDR股票交易,健康照护类股ETF-SPDR股票购买,健康照护类股ETF-SPDR股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"健康照护类股ETF-SPDR(XLV)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供健康照护类股ETF-SPDR(XLV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}